Thyroid Cancer Breakthrough News
|
|
June 19, 2008
ENDO: Sorafenib Active in Advanced Thyroid Cancer |
|
|
By Charles Bankhead, Staff Writer, MedPage Today
WASHINGTON, June 19 -- Almost two-thirds of patients with advanced thyroid cancer benefited from treatment with the tyrosine kinase inhibitor
sorafenib (Nexavar), data from a small clinical trial showed.
< READ MORE > |
|
|
|
|
June 16, 2008
ENDO: Low-Dose Radiation Matches High-Dose in Thyroid Cancer |
|
|
By Charles Bankhead, Staff Writer, MedPage Today
WASHINGTON -- Low-dose adjuvant radiation therapy clears thyroid cancer remnants as effectively as high-dose therapy, according to preliminary data from an ongoing study.
< READ MORE > |
|
|
|
|
June 19, 2008
ENDO: Sorafenib Active in Advanced Thyroid Cancer |
|
|
By Charles Bankhead, Staff Writer, MedPage Today
WASHINGTON, June 19 -- Almost two-thirds of patients with advanced thyroid cancer benefited from treatment with the tyrosine kinase inhibitor
sorafenib (Nexavar), data from a small clinical trial showed.
< READ MORE > |
|
|
|
|
July 2, 2008
Investigational VEGF Inhibitor Found 'Clinically Meaningful' for Metastatic Thyroid Cancer |
|
|
By Todd
Neale, Staff Writer, MedPage
Today
HOUSTON, July 2 -- For some patients with metastatic thyroid cancer, an investigational targeted drug can induce partial
responses, according to a small multicenter, phase II trial in the U.S. and Europe.
< READ MORE > |
|
|
|
|
May 19, 2008
Gene Test May Improve Thyroid Cancer Diagnosis |
|
|
By
Michael Smith, North American Correspondent, MedPage
Today
ROME, May 19 -- A test
for the molecule galectin-3 may improve the
diagnosis of thyroid cancer and reduce the number of
unneeded surgeries, researchers here said.
< READ MORE > |
|
|
|
|
|
